REDENTI, SARA
REDENTI, SARA
Dipartimento di Scienze Chimiche e Farmaceutiche
5,7-Disubstituted-[1,2,4]triazolo[1,5-a][1,3,5]triazines as pharmacological tools to explore the antagonist selectivity profiles toward adenosine receptors
2016-01-01 Federico, Stephanie; Ciancetta, Antonella; Porta, Nicola; Redenti, Sara; Pastorin, Giorgia; Cacciari, Barbara; Klotz, Karl Norbert; Moro, Stefano; Spalluto, Giampiero
[1,2,4]triazolo[1,5-c]pyrimidines as A(3) adenosine receptor antagonists
2014-01-01 Federico, Stephanie; Redenti, Sara; Ciancetta, Antonella; Cacciari, Barbara; Klotz, Karl Norbert; Moro, Stefano; Spalluto, Giampiero
A Triazolotriazine-Based Dual GSK-3β/CK-1δ Ligand as a Potential Neuroprotective Agent Presenting Two Different Mechanisms of Enzymatic Inhibition
2019-01-01 Redenti, Sara; Marcovich, Irene; De Vita, Teresa; Pérez, Concepción; De Zorzi, Rita; Demitri, Nicola; Perez, Daniel I.; Bottegoni, Giovanni; Bisignano, Paola; Bissaro, Maicol; Moro, Stefano; Martinez, Ana; Storici, Paola; Spalluto, Giampiero; Cavalli, Andrea; Federico, Stephanie
Conjugable A3 Adenosine Receptor Antagonists: Probing the 5 Position of the Pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidine Scaffold.
2014-01-01 Federico, Stephanie; Redenti, Sara; Klotz, Karl Norbert; Moro, Stefano; Spalluto, Giampiero
CVT 6975-like Pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidine Derivatives: an Attempt towards A2B Adenosine Receptor Affinity.
2014-01-01 Redenti, Sara; Federico, Stephanie; Klotz, Karl Norbert; Moro, Stefano; Spalluto, Giampiero
DESIGN, SYNTHESIS AND CHARACTERIZATION OF GSK-3β AND CK-1δ INHIBITORS
2017-05-04 Redenti, Sara
Developing novel classes of protein kinase CK1δ inhibitors by fusing [1,2,4]triazole with different bicyclic heteroaromatic systems
2021-01-01 Grieco, I.; Bissaro, M.; Tiz, D. B.; Perez, D. I.; Perez, C.; Martinez, A.; Redenti, S.; Mariotto, E.; Bortolozzi, R.; Viola, G.; Cozza, G.; Spalluto, G.; Moro, S.; Federico, S.
Mixed-reversible and covalent kinase inhibition as a possible new strategy to treat neuro-inflammatory/degenerative diseases
2019-01-01 Redenti, Sara; Marcovich, Irene; De Vita, Teresa; Pérez, Carmen; DE ZORZI, Rita; Demitri, Nicola; Perez, Daniel . I.; Bottegoni, Giovanni; Bisignano, Paola; Bissaro, Maicol; Moro, Stefano; Martinez, Ana; Giabbai, Barabara; Storici, Paola; Spalluto, Giampiero; Cavalli, Andrea; Federico, Stephanie
N8-Isopentyl and N8-Phenylethyl Pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidine Derivatives as Adenosine Receptor Antagonists
2014-01-01 Federico, Stephanie; Redenti, Sara; Klotz, Karl Norbert; Moro, Stefano; Spalluto, Giampiero
Pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidines and Structurally Simplified Analogs. Chemistry and SAR Profile as Adenosine Receptor Antagonists
2016-01-01 Redenti, Sara; Ciancetta, Antonella; Pastorin, Giorgia; Cacciari, Barbara; Moro, Stefano; Spalluto, Giampiero; Federico, Stephanie
Scaffold decoration at positions 5 and 8 of 1,2,4-triazolo[1,5- c ]pyrimidines to explore the antagonist profiling on adenosine receptors: A preliminary structure-activity relationship study
2014-01-01 Federico, Stephanie; Ciancetta, Antonella; Porta, Nicola; Redenti, Sara; Pastorin, Giorgia; Cacciari, Barbara; Klotz, Karl Norbert; Moro, Stefano; Spalluto, Giampiero
The Influence of the 1-(3-Trifluoromethyl-Benzyl)-1H-Pyrazole-4-yl Moiety on the Adenosine Receptors Affinity Profile of Pyrazolo[4,3-e][1,2,4]Triazolo[1,5-c]Pyrimidine Derivatives
2015-01-01 Federico, Stephanie; Redenti, Sara; Sturlese, Mattia; Ciancetta, Antonella; Kachler, Sonja; Klotz, Karl Norbert; Cacciari, Barbara; Moro, Stefano; Spalluto, Giampiero